Skip to main content
Techno Medica Co., Ltd. logo

Techno Medica Co., Ltd. — Investor Relations & Filings

Ticker · 6678 ISIN · JP3545110003 T Manufacturing
Open in API
Filings indexed 67 across all filing types
Latest filing 2022-11-10 Report Publication Anno…
Country JP Japan
Listing T 6678

About Techno Medica Co., Ltd.

https://www.technomedica.co.jp/t01/Engl…

Techno Medica Co., Ltd. specializes in the research, development, manufacturing, and sale of in-vitro diagnostic (IVD) analyzers and automated pre-analytical systems for clinical laboratories. The company provides solutions that automate the workflow for blood and urine testing, covering processes from test registration and pre-analysis to patient identification and specimen transfer management. Its product portfolio includes next-generation IVD analyzers, such as electrolyte analyzers, and it is a leading manufacturer in the test tube market. The company focuses on delivering innovative products and services designed to enhance the efficiency, accuracy, and safety of laboratory diagnostics.

Recent filings

Filing Released Lang Actions
確認書
Report Publication Announcement Classification · 100% confidence The document is a 'Confirmation Letter' (Kakunin-sho) filed under the Financial Instruments and Exchange Act, specifically related to the accuracy of the Second Quarter Report (Interim Report). While it references the quarterly report, the document itself is a formal regulatory filing confirming the validity of the financial statements for the period ending September 30, 2022. Since it is a specific regulatory requirement for filing financial reports in Japan and does not fit into the 'Interim Report' (IR) category itself (which would be the full financial report), it is best classified as a Regulatory Filing (RNS).
2022-11-10 Japanese
四半期報告書－第36期第2四半期(令和4年7月1日－令和4年9月30日)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) for Techno Medica Co., Ltd., covering the second quarter of the 36th fiscal period (April 1, 2022, to September 30, 2022). It contains detailed financial statements, including the balance sheet and income statement, and is filed in accordance with the Financial Instruments and Exchange Act of Japan. As it is a comprehensive financial report for a period shorter than a full fiscal year containing actual financial data, it is classified as an Interim/Quarterly Report. H1 2023
2022-11-10 Japanese
確認書
Report Publication Announcement Classification · 100% confidence The document is a 'Confirmation Letter' (Kakunin-sho) filed under the Financial Instruments and Exchange Act, specifically accompanying a Quarterly Report (Dai-ichi shihanki hokokusho). While it references a quarterly report, the document itself is a formal regulatory confirmation statement required by Japanese law to accompany the filing. Since it is a specific regulatory filing required by the Kanto Local Finance Bureau and does not contain the full financial statements themselves, it falls under the Regulatory Filings category.
2022-08-09 Japanese
四半期報告書－第36期第1四半期(令和4年4月1日－令和4年6月30日)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) for Techno Medica Co., Ltd., covering the first quarter of the 36th fiscal year (April 1, 2022, to June 30, 2022). It contains detailed financial statements, including the balance sheet and income statement, as well as management analysis and notes. This fits the definition of an Interim/Quarterly Report (IR) as it provides comprehensive financial data for a period shorter than a full fiscal year. Q1 2023
2022-08-09 Japanese
確認書
Regulatory Filings Classification · 95% confidence The document is a 'Confirmation Letter' (確認書) filed under the Financial Instruments and Exchange Act. It serves as an officer certification regarding the accuracy of the company's Annual Securities Report (有価証券報告書). According to the 'Certification Rule', documents that are primarily officer certifications or attestations, even if they reference a specific report, should be classified as Regulatory Filings (RNS). FY 2022
2022-06-28 Japanese
内部統制報告書－第35期(令和4年6月27日－令和4年6月27日)
Governance Information Classification · 100% confidence The document is an 'Internal Control Report' (内部統制報告書) filed under the Financial Instruments and Exchange Act (金融商品取引法) in Japan. This type of report details the company's internal control framework, evaluation scope, and results regarding financial reporting. Since it is a specific regulatory filing concerning internal controls and does not fit into the other categories like 10-K or IR, it is best classified as a Regulatory Filing (RNS).
2022-06-28 Japanese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.